T. Wiersma

1.4k total citations
25 papers, 288 citations indexed

About

T. Wiersma is a scholar working on Cancer Research, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, T. Wiersma has authored 25 papers receiving a total of 288 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Cancer Research, 13 papers in Oncology and 12 papers in Pulmonary and Respiratory Medicine. Recurrent topics in T. Wiersma's work include Breast Cancer Treatment Studies (15 papers), Breast Lesions and Carcinomas (6 papers) and Cancer Treatment and Pharmacology (6 papers). T. Wiersma is often cited by papers focused on Breast Cancer Treatment Studies (15 papers), Breast Lesions and Carcinomas (6 papers) and Cancer Treatment and Pharmacology (6 papers). T. Wiersma collaborates with scholars based in Netherlands, Belgium and United States. T. Wiersma's co-authors include Gabe S. Sonke, Erik van Werkhoven, Marie-Jeanne T. F. D. Vrancken Peeters, Frederieke van Duijnhoven, Marieke E. M. van der Noordaa, Claudette E. Loo, Koen Van de Vijver, Hugo M. Horlings, Tessa G. Steenbruggen and Tomas Janssen and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

T. Wiersma

23 papers receiving 281 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
T. Wiersma Netherlands	11	150	143	92	81	76	25	288
Eliana La Rocca Italy	8	168 1.1×	116 0.8×	44 0.5×	106 1.3×	50 0.7×	30	278
Jean‐Remi Garbay France	4	236 1.6×	147 1.0×	50 0.5×	86 1.1×	49 0.6×	4	338
Tse-Kuan Yu United States	9	208 1.4×	229 1.6×	96 1.0×	60 0.7×	55 0.7×	9	382
Luigia Nardone Italy	11	119 0.8×	76 0.5×	67 0.7×	47 0.6×	184 2.4×	18	308
D.J. DiCostanzo United States	10	92 0.6×	82 0.6×	117 1.3×	42 0.5×	62 0.8×	29	267
Elisa Tardelli Italy	10	76 0.5×	88 0.6×	109 1.2×	32 0.4×	132 1.7×	15	297
N. Rodríguez-Spiteri Spain	8	115 0.8×	89 0.6×	171 1.9×	42 0.5×	190 2.5×	23	359
Tobias Lekberg Sweden	9	138 0.9×	150 1.0×	45 0.5×	34 0.4×	47 0.6×	12	270
Meghan Butler United States	5	252 1.7×	130 0.9×	48 0.5×	136 1.7×	50 0.7×	7	388
Charleen Chan Wah Hak United Kingdom	5	132 0.9×	66 0.5×	58 0.6×	32 0.4×	56 0.7×	7	238

Countries citing papers authored by T. Wiersma

Since Specialization

Citations

This map shows the geographic impact of T. Wiersma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T. Wiersma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T. Wiersma more than expected).

Fields of papers citing papers by T. Wiersma

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T. Wiersma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T. Wiersma. The network helps show where T. Wiersma may publish in the future.

Co-authorship network of co-authors of T. Wiersma

This figure shows the co-authorship network connecting the top 25 collaborators of T. Wiersma. A scholar is included among the top collaborators of T. Wiersma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T. Wiersma. T. Wiersma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wiersma, T., J. Knegjens, Arash Navran, et al.. (2024). Local control and toxicity after stereotactic radiotherapy in brain metastases patients and the impact of novel systemic treatments. Radiotherapy and Oncology. 200. 110540–110540. 1 indexed citations

Duijnhoven, Frederieke van, et al.. (2023). Biopsy-Guided Pathological Response Assessment in Breast Cancer is Insufficient: Additional Pathology Findings of the MICRA Trial. Annals of Surgical Oncology. 30(8). 4682–4689. 3 indexed citations

Steenbruggen, Tessa G., et al.. (2023). Abstract OT2-15-01: COntinue the SaMe systemic therapy after local ablative therapy for Oligoprogression in metastatic breast cancer - the COSMO study. Cancer Research. 83(5_Supplement). OT2–15.

Schie, Petra van, Mariska Bot, T. Wiersma, et al.. (2023). Optimizing treatment of brain metastases in an era of novel systemic treatments: a single center consecutive series. Journal of Neuro-Oncology. 163(2). 345–354. 3 indexed citations

Steenbruggen, Tessa G., et al.. (2022). Survival and prognostic factors in oligometastatic breast cancer. The Breast. 67. 14–20. 4 indexed citations

Steenbruggen, Tessa G., et al.. (2022). Survival and prognostic factors in oligometastatic breast cancer.. Journal of Clinical Oncology. 40(16_suppl). 1089–1089. 1 indexed citations

Steenbruggen, Tessa G., Michael Schaapveld, Hugo M. Horlings, et al.. (2021). Characterization of Oligometastatic Disease in a Real-World Nationwide Cohort of 3447 Patients With de Novo Metastatic Breast Cancer. JNCI Cancer Spectrum. 5(3). 18 indexed citations

Wiersma, T., et al.. (2021). Characterization of automatic treatment planning approaches in radiotherapy. Physics and Imaging in Radiation Oncology. 19. 60–65. 15 indexed citations

Noordaa, Marieke E. M. van der, Emiel J. Rutgers, Erik van Werkhoven, et al.. (2021). Breast-Conserving Therapy in Patients with cT3 Breast Cancer with Good Response to Neoadjuvant Systemic Therapy Results in Excellent Local Control: A Comprehensive Cancer Center Experience. Annals of Surgical Oncology. 28(12). 7383–7394. 8 indexed citations

10.

Noordaa, Marieke E. M. van der, Erik van Werkhoven, Claudette E. Loo, et al.. (2020). Minimally Invasive Complete Response Assessment of the Breast After Neoadjuvant Systemic Therapy for Early Breast Cancer (MICRA trial): Interim Analysis of a Multicenter Observational Cohort Study. Annals of Surgical Oncology. 28(6). 3243–3253. 51 indexed citations

11.

Steenbruggen, Tessa G., Winnie Schats, T. Wiersma, et al.. (2020). Prognostic factors in patients with oligometastatic breast cancer – A systematic review. Cancer Treatment Reviews. 91. 102114–102114. 22 indexed citations

12.

Peeters, Marie-Jeanne T. F. D. Vrancken, Frederieke van Duijnhoven, Claudette E. Loo, et al.. (2020). Abstract GS5-06: Towards omitting breast surgery in patients with a pathologic complete response after neoadjuvant systemic treatment: interim analysis of the MICRA trial (Minimally Invasive Complete Response Assessment). Cancer Research. 80(4_Supplement). GS5–6. 9 indexed citations

13.

Noordaa, Marieke E. M. van der, Erik van Werkhoven, Claudette E. Loo, et al.. (2020). Minimally Invasive Complete Response Assessment of the breast after neoadjuvant systemic therapy (MICRA trial): Interim analysis of a multicenter observational cohort study. European Journal of Cancer. 138. S9–S10. 2 indexed citations

14.

Wiersma, T., et al.. (2019). Geometrical and dosimetric evaluation of breast target volume auto-contouring. Physics and Imaging in Radiation Oncology. 12. 38–43. 15 indexed citations

15.

Noordaa, Marieke E. M. van der, Frederieke van Duijnhoven, Claudette E. Loo, et al.. (2018). Identifying pathologic complete response of the breast after neoadjuvant systemic therapy with ultrasound guided biopsy to eventually omit surgery: Study design and feasibility of the MICRA trial (Minimally Invasive Complete Response Assessment). The Breast. 40. 76–81. 22 indexed citations

16.

Kok, Marleen, Leonie Voorwerk, Hugo M. Horlings, et al.. (2018). Adaptive phase II randomized trial of nivolumab after induction treatment in triple negative breast cancer (TONIC trial): Final response data stage I and first translational data.. Journal of Clinical Oncology. 36(15_suppl). 1012–1012. 34 indexed citations

17.

Kok, Marleen, Hugo M. Horlings, T. Wiersma, et al.. (2017). Adaptive phase II randomized non-comparative trial of nivolumab after induction treatment in triple negative breast cancer: TONIC-trial. Annals of Oncology. 28. v608–v608. 21 indexed citations

18.

Wiersema, Lisa, Gerben R. Borst, Heike Peulen, et al.. (2017). EP-1838: First IGRT results for SBRT bone and lymph node oligometastases within the pelvic region. Radiotherapy and Oncology. 123. S1006–S1006. 4 indexed citations

19.

Rodrigues, George, Suresh Senan, Cary Oberije, et al.. (2014). Is Intermediate Radiation Dose Escalation With Concurrent Chemotherapy for Stage III Non-Small Cell Lung Cancer Beneficial?: A Multi-institutional Propensity-Score Matched Analysis. International Journal of Radiation Oncology*Biology*Physics. 90(1). S654–S654. 2 indexed citations

20.

Wiersma, T., Max Dahele, Wilko F.A.R. Verbakel, et al.. (2013). Concurrent chemoradiotherapy for large-volume locally-advanced non-small cell lung cancer. Lung Cancer. 80(1). 62–67. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact